Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734289 · ClinicalTrials.gov registry record · NA
Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI
A NA study of Dementia and Traumatic Brain Injury, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT03734289: Completed NA study of Dementia and Traumatic Brain Injury, sponsored by University of Alabama at Birmingham.
NCT03734289 is a NA study of Dementia and Traumatic Brain Injury that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 88 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03734289, a NA study of Dementia and Traumatic Brain Injury, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
To reduce care resistant behaviors (CRB) among people with dementia residing in nursing homes, to a distance-learning education, training, and coaching program for family caregivers of people with dementia or TBI; assess the efficacy of the intervention for reducing frequency or severity of CRB-triggered symptoms of agitation, aggression, and irritability; assess the efficacy of the intervention for improving quality of life of patients, caregivers, and families; and determine how patient and caregiver characteristics influence the effectiveness of the intervention. 5\. Evaluate how the intervention affects the health care costs of people with dementia or TBI.
Primary Outcome
A measure of caregiver burden
Conditions Studied
Interventions
- BEHAVIORAL Caregiver Coaching
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT03734289 record still lists
NCT03734289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Caregiver Coaching is the first listed.
NCT03734289 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03734289 about?
NCT03734289 is a clinical study titled "Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI". To reduce care resistant behaviors (CRB) among people with dementia residing in nursing homes, to a distance-learning education, training, and coaching program for family caregivers of people with dementia or TBI; assess the efficacy of the intervention for reducing frequency or severity of CRB-trig...
What is the current status of trial NCT03734289?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2017-02-01. Estimated completion is 2021-08-31.
What conditions does trial NCT03734289 study?
This clinical trial studies the following conditions: Dementia, Traumatic Brain Injury.
What interventions are being tested in trial NCT03734289?
The interventions under investigation include: Caregiver Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03734289?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03734289 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03734289's enrollment target sits among peer trials
88 125th of 199 higher than 74 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI